Publications by authors named "Laura Visa"

Claim this Profile
D
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.
Lucía Mateos, Paula Jiménez-Fonseca, Javier Gallego, Arturo Lecumberri, Ana Custodio, Laura Visa

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
Mónica Guillot Morales, Laura Visa, Elena Brozos Vázquez, Jaime Feliu Batlle, Parham Khosravi Shahi

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Aranzazu Arias-Martinez, Eva Martínez de Castro, Javier Gallego, Virginia Arrazubi, Ana Custodio, Laura Visa

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Pablo Pérez-Wert, Ana Custodio, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Arturo Lecumberri, Laura Visa

Gastric Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in oncological patients with solid tumours requiring intensive care unit admission.
Raquel Bosch-Compte, Laura Visa, Alejandro Rios, Xavier Duran, Maria Fernández-Real

Oncol Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
Sena Valcarcel, Javier Gallego, Paula Jimenez-Fonseca, Marc Diez, Eva Martínez de Castro, Laura Visa

J Cancer Res Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Laura Visa

Ther Adv Med Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of complications associated to bile duct stents, in patients with advanced cancer: a single-center experience.
Alex Corbera, Alejandro Rios-Hoyo, Laura Visa, David Casadevall, Lucas Ilzarbe

Support Care Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis.
Neus Martínez-Bosch, Helena Cristóbal, Mar Iglesias, Meritxell Gironella, Luis Barranco, Laura Visa

EBioMedicine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial.
Aleksandar Radosevic, Rita Quesada, Clara Serlavos, Juan Sánchez, Ander Zugazaga, Laura Visa

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry.
David Zaragoza-Huesca, Pedro Garrido-Rodríguez, Paula Jiménez-Fonseca, Eva Martínez de Castro, Manuel Sánchez-Cánovas, Laura Visa

Biomedicines· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Felipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Virginia Arrazubi, Raquel Hernandez, Laura Visa

Gastric Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, Maria Alsina, Ana Custodio, Laura Visa

Ther Adv Med Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study.
Núria Argudo, Anna Rodó-Pin, Juana Martínez-Llorens, Ester Marco, Laura Visa

Dis Esophagus· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Eva Martínez de Castro, Ana Custodio, Carles Pericay Pijaume, Laura Visa

Gastric Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal Wall Metastasis of Pancreatic Cancer: The Tip of the Iceberg-Case Report.
Luis Eduardo Casasola-Sánchez, Fernando Burdio-Pinilla, José Antonio Pereira-Rodríguez, Aleksandar Radosevic, Laura Visa

Pancreas· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
Almudena Cotes Sanchís, Javier Gallego, Raquel Hernandez, Virginia Arrazubi, Ana Custodio, Laura Visa

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
Berta Laquente, Teresa Macarulla, Cristina Bugés, Marta Martín, Carlos García, Laura Visa

BMC Palliat Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer.
Noemí Manero-Rupérez, Neus Martínez-Bosch, Luis E Barranco, Laura Visa, Pilar Navarro

Cells· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Marcelo Garrido, Ana Custodio, Raquel Hernandez, Laura Visa

Thromb Haemost· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer.
Aïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí, Laura Visa, Mar Iglesias

Mol Cancer Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
Joan Maurel, Santiago Sánchez-Cabús, Berta Laquente, Lydia Gaba, Laura Visa

Cancer Chemother Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy: The PADULAP Randomized Controlled Trial.
Ignasi Poves, Fernando Burdío, Olga Morató, Mar Iglesias, Aleksander Radosevic, Laura Visa

Ann Surg· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Isabel Echavarria, Manuel Sánchez Cánovas, Gema Aguado, Laura Visa

Eur J Surg Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker.
Neus Martinez-Bosch, Luis E Barranco, Carlos A Orozco, Mireia Moreno, Laura Visa

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis